Clinical effect and adverse reaction of tiggio combined with oxaliplatin on the treatment of advanced gastric
10.3969/j.issn.1005-1678.2017.09.129
- VernacularTitle:替吉奥联合奥沙利铂治疗晚期胃癌的临床效果与不良反应观察
- Author:
Wencong GAO
;
Yonglin WANG
- Keywords:
tiggio;
oxaliplatin;
advanced gastric cancer
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(9):290-292
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the clinical effect and adverse effects of tiggio combined with oxaliplatin on the treatment of advanced gastric cancer. Methods From January 2014 to January 2017, 88 cases with advanced gastric cancer were selected as the samples in Yangling demonstration zone hospital. All the patients were randomly divided into the control group (n = 44) and the observation group (n = 44). The control group and the observation group were treated with tiggio and tiggio combined with oxaliplatin respectively, and the clinical effect and the occurrence of adverse reactions in the two groups was compared. Results The total effect in the observation group was 91.0%, which was significantly higher than that in the control group (75.0%), (P<0.05); The incidence of adverse reactions in the control group was 27.3%, while in the observation group was 9.1% the difference was statistically significant(P<0.05). Conclusion Tiggio combined with oxaliplatin in the treatment of advanced gastric cancer, the clinical effect is significant, the incidence of adverse reactions is low, high security, worthy of promotion.